Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Christer Rosen | Co-Founder, CEO & Chairman of the Board | 4.29k | -- | 1952 |
| Ms. Alison D. Silva MA, MS | President, Chief Business Officer & Director | 35k | -- | 1979 |
| Dr. Marshall Hayward Ph.D. | Co-Founder, Chief Scientific Officer & Director | 18.65k | -- | 1957 |
| Mr. Alexander Rosen | Co-Founder & Chief Administrative Officer | 27.26k | -- | 1991 |
| Mr. Saleem Elmasri CPA | CFO & Secretary | -- | -- | 1987 |
| Dr. Claes Wahlestedt M.D., Ph.D. | Co-Founder, Co-Chairman of Scientific Advisory Board & Consulting Chief Medical Officer | -- | -- | 1958 |
| Dr. Shaun P. Brothers Ph.D. | Co-Founder and Consulting Vice President of Science Research | -- | -- | 1979 |
Jupiter Neurosciences, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 4
Description
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform products primarily for the treatment of neuroinflammation. It is developing JNS101, which is in Phase II trial for the treatment of Friedreich's Ataxia, a rare inherited disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS108 that is in Phase II trial for treating mild cognitive impairment/early Alzheimer's disease. The company is also developing JNS102, which is in Phase II trial for the treatment of mucopolysaccharidosis type 1; and JNS107 that is in Phase II trial for treating mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome. In addition, it is developing JNS115, which is in Phase II trial for the treatment of Parkinson's disease. It has a strategic partnership with Zina Biopharmaceuticals, LLC to Advance Phase 2a Parkinson's Trial. The company has a strategic partnership with Aquanova AG to jointly develop a series of consumer-focused nutritional products targeting longevity, aging, and healthspan. The company was formerly known as Jupiter Orphan Therapeutics, Inc. and changed its name to Jupiter Neurosciences, Inc. in August 2021. Jupiter Neurosciences, Inc. was incorporated in 2015 and is headquartered in Jupiter, Florida.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
November 7, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
September 13, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
September 4, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
September 3, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission